Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka rewards digital health startup NeuroFlow

Mental illness tech platform wins the pharma firm's US pitch challenge

Otsuka pharmaOtsuka’s US challenge for digital health startups has been won by NeuroFlow, a Philadelphia-based company working on technology to support people with mental health issues.

The firm’s soon-to-launch technology captures real-time and secure patient-generated data to support patients with their treatments via monitoring, positive reinforcement, and targeted guidance.

NeuroFlow beat five other entrepreneurs in Otsuka’s live Pitch Challenge, held last month at the Elevate by Psych Congress event in Austin, Texas, to take home the $5,000 winner’s prize.

Andrew Wright, vice president of digital medicine for Otsuka, said: “At Otsuka, we are proud of our commitment to developing innovative solutions. At the heart of this work is addressing mental health disorders and supporting patients and caregivers.

“We are thrilled to support this Pitch Event and Elevate by Psych Congress. By convening some of the best entrepreneurs in technology and mental health, and giving them an opportunity to engage directly with the leading experts in the field, we can spark new conversations and road-test new ideas.”

The challenge fits firmly within the pharma trend of running competitions to identify outside digital health startups to support, as seen at the likes of Sandoz, Bayer and Sanofi.

At Otsuka’s event the companies competing covered a range of technology, focusing on areas such as medication adherence, mental health literacy and the need for understanding side effects and medication regimes.

NeuroFlow’s winning pitch was for work that promotes better health outcomes for patients and business growth for healthcare providers by helping to improve treatment retention and protocol adherence.

Christopher Molaro, NeuroFlow CEO and co-founder, said: “The support of Otsuka and Psych Congress is exciting to everyone at NeuroFlow. The fact Psych Congress attendees chose NeuroFlow is validation to the value of our technology and to our belief that technology can play an important role in understanding and supporting those with mental illness and thank Otsuka for their support in that journey.”

7th March 2018

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics